Yahoo Web Search

Search results

    • American healthcare biotech venture capitalist

      • Amy Weinfeld Schulman is an American healthcare biotech venture capitalist, trained as a lawyer, who serves as a managing partner at Polaris Partners. She focuses on investing in healthcare companies and early-stage biotech start-ups. She also chairs the Board of Directors for Alnylam Pharmaceuticals (NASDAQ: ALNY) and ByHeart, and represents Polaris as a director for Kallyope, Thirty Madison, QurAlis, and Larkspur.
      en.wikipedia.org › wiki › Amy_Schulman
  1. en.wikipedia.org › wiki › Amy_SchulmanAmy Schulman - Wikipedia

    Sep 3, 2024 · Amy Weinfeld Schulman is an American healthcare biotech venture capitalist, trained as a lawyer, who serves as a managing partner at Polaris Partners. [1] [2] [3] She focuses on investing in healthcare companies and early-stage biotech start-ups.

  2. People also ask

  3. Amy is a managing partner at Polaris Partners who focuses on investing in healthcare companies and early stage biotech start-ups. She serves as chair of the Board of Directors of Alnylam Pharmaceuticals (NASDAQ: ALNY) and as chair of the Board of Directors of ByHeart.

  4. Amy Weinfeld Schulman is an American healthcare biotech venture capitalist, trained as a lawyer, who serves as a managing partner at Polaris Partners. [1] [2] [3] She focuses on investing in healthcare companies and early-stage biotech start-ups.

  5. Amy W. Schulman is an accomplished business leader, widely recognized for growing and stabilizing global businesses, commitment to people, strategic judgment, and efforts to advance women and promote inclusive workplace cultures. Ms. Schulman joined Harvard Business School’s Faculty as a Senior Lecturer in July 2014.

  6. Amy Schulman is a Managing Partner at Polaris Partners, a venture capital firm, and co-founder of the Polaris Innovation Fund. She currently serves as executive chair of Lyndra Therapeutics, which she co-founded and served as the company's initial CEO.

  7. Mar 5, 2024 · As former leader of Pfizer's infant nutrition and consumer healthcare businesses, Schulman brings extensive experience in the space, in addition to serving on the boards of several biotech...

  8. Sep 13, 2023 · Amy Schulman, managing partner at venture capital firm Polaris Partners and co-founder of the Polaris Innovation Fund, was recently elected to Caltech's Board of Trustees.

  1. People also search for